Bharadwaj P, Luthra M
Senior Advisor (Medicine & Cardiologist), MH (CTC), Pune.
Senior Advisor (Surgery & Cardio-Thoracic Surgery), AH R&R, Delhi Cantt.
Med J Armed Forces India. 2008 Apr;64(2):154-7. doi: 10.1016/S0377-1237(08)80063-9. Epub 2011 Jul 21.
The high prevalence of coronary artery disease has inspired the development of technologies and techniques for coronary revascularisation, including coronary artery bypass grafting (CABG) and percutaneous coronary interventions (PCI). PCI have witnessed the impact of innovation with newer hardware and drug eluting stents (DES). DES have indisputably reduced restenosis, however there is an emerging concern over the risk of late stent thrombosis associated with their use. We discuss the limitations of the current generation DES and review advances in the stent technology. The technology used in CABG has improved, resulting in off-pump coronary artery bypass (OPCAB), endoscopic, video-assisted, and robot-assisted CABG with automated one-shot distal anastomotic devices being used increasingly. The difference in adverse outcomes between CABG and PCI continues to decline and the future may witness a close collaboration between the two.
冠状动脉疾病的高发病率推动了冠状动脉血运重建技术的发展,包括冠状动脉旁路移植术(CABG)和经皮冠状动脉介入治疗(PCI)。PCI见证了新型硬件和药物洗脱支架(DES)创新所带来的影响。DES无疑减少了再狭窄,但人们对其使用相关的晚期支架血栓形成风险日益担忧。我们讨论了当代DES的局限性,并回顾了支架技术的进展。CABG所采用的技术已有所改进,出现了非体外循环冠状动脉旁路移植术(OPCAB)、内镜、视频辅助和机器人辅助的CABG,且自动一次性远端吻合装置的使用越来越多。CABG和PCI在不良结局方面的差异持续缩小,未来两者可能会密切合作。